ORGN:NASDAQOrigin Materials, Inc. Analysis
Data as of 2026-04-22 - not real-time
$2.30
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Origin Materials is trading well below its longer‑term averages, with the 20‑day SMA at $2.39 versus the 50‑day SMA of $3.49 and the 200‑day SMA of $11.94, underscoring a deep bearish bias. The RSI sits around 39, suggesting limited upside momentum, while the MACD histogram is modestly positive, hinting at a faint bullish crossover that has yet to translate into price strength. Current price of $2.30 hovers just above the calculated support of $1.88 and well below the resistance of $4.11, leaving little room for a rally without a catalyst. Volume is on a decreasing trend, amplifying the downside risk as liquidity dries up. The stock’s volatility is extreme at over 150% for the past 30 days, and a beta of 1.76 signals heightened sensitivity to market swings.
Fundamentally, the company is in distress: revenue has collapsed by roughly 67%, gross margins are a meager 2.9%, and operating margins are negative at -5.2%. Cash flow is negative, with operating cash flow around -$32.8M and free cash flow near -$40.7M**, yet the balance sheet shows a cash pile of $53.5M against $27.7M of debt, providing a modest cushion. The market caps the company at just $12.5M, and the price‑to‑book ratio of 0.11 and price‑to‑sales of 0.66 reflect severe discounting, though the lack of earnings makes valuation ambiguous. The “Extreme Greed” sentiment index at 87.11 appears disconnected from the underlying fundamentals, and recent earnings‑call commentary highlights ongoing liquidity constraints, reinforcing the need for caution.
Fundamentally, the company is in distress: revenue has collapsed by roughly 67%, gross margins are a meager 2.9%, and operating margins are negative at -5.2%. Cash flow is negative, with operating cash flow around -$32.8M and free cash flow near -$40.7M**, yet the balance sheet shows a cash pile of $53.5M against $27.7M of debt, providing a modest cushion. The market caps the company at just $12.5M, and the price‑to‑book ratio of 0.11 and price‑to‑sales of 0.66 reflect severe discounting, though the lack of earnings makes valuation ambiguous. The “Extreme Greed” sentiment index at 87.11 appears disconnected from the underlying fundamentals, and recent earnings‑call commentary highlights ongoing liquidity constraints, reinforcing the need for caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price well below all moving averages
- Decreasing volume and high volatility
- Negative cash flow and operating losses
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside if cash runway extends
- Low valuation multiples may attract contrarian interest
- Regulatory and execution risk remain elevated
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Strategic positioning in carbon‑negative materials
- Fundamental financial health still weak
- Uncertain path to profitability and scale
Key Metrics & Analysis
Financial Health
Revenue Growth-67.20%
P/E Ratio-6.6
ROE-112.84%
ROA-14.81%
Debt/Equity26.59
P/B Ratio0.1
Op. Cash Flow$-32793000
Free Cash Flow$-40731500
Technical Analysis
TrendBearish
RSI39.4
Support$1.88
Resistance$4.11
MA 20$2.39
MA 50$3.49
MA 200$11.94
MACDBullish
VolumeDecreasing
Fear & Greed Index87.11
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.76
Volatility153.81%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.